San Diego, CA, United States of America

Martha A Wild

USPTO Granted Patents = 10 

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 1999-2011

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Martha A. Wild in Infectious Disease Research

Introduction: Martha A. Wild, an accomplished inventor based in San Diego, California, has made significant contributions to the field of veterinary medicine with a focus on avian diseases. With a total of ten patents to her name, she has demonstrated a strong commitment to innovation and the advancement of animal health.

Latest Patents: Among her most notable inventions is the patent for a recombinant infectious laryngotracheitis virus and uses thereof. This invention presents a recombinant, attenuated infectious laryngotracheitis virus that includes a deletion in the glycoprotein gG gene. The innovative approach offers a viable vaccine against the infectious laryngotracheitis virus, enhancing poultry health. Additionally, this patent outlines methods for distinguishing vaccinated chickens from those infected with the naturally occurring virus, addressing critical challenges in poultry disease management.

Career Highlights: Martha A. Wild has built her career through pivotal roles in well-regarded companies, including Schering-Plough Animal Health Corporation and Syntro Corporation. Her work has not only led to significant patent filings but also to advancements in understanding and combating infectious diseases in poultry, showing her dedication to improving animal welfare.

Collaborations: Throughout her career, Martha has had the opportunity to collaborate with esteemed colleagues including Mark D. Cochran and Stephanie M. Cook. These partnerships have allowed her to integrate diverse expertise in her research, fostering an environment of innovation and discovery.

Conclusion: Martha A. Wild exemplifies the spirit of innovation in the field of veterinary medicine. Her work on the recombinant infectious laryngotracheitis virus not only contributes to scientific knowledge but also serves practical applications in the industry. With her impressive portfolio of patents and collaborations, she continues to impact the future of animal health positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…